Conversely, as in naive animals, CD4 was undetectable in the EAE group treated with hPDLSCs-CM or hPDLSCs-EMVs obtained from MS patients [Fig. 9S] and donors [Fig. 9T]. Here, CD4 is linked to myeloid sarcoma.